Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Imitrodast is a small molecule thromboxane A2 synthase (TXA2 synthase) inhibitor for the treatment of immune system disorders, respiratory disorders, and cardiovascular diseases, and can be used in studies of arterial thrombosis, asthma, and coronary vasospasm.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 210.00 | |
5 mg | In stock | $ 540.00 | |
10 mg | In stock | $ 779.00 | |
25 mg | In stock | $ 1,180.00 | |
50 mg | In stock | $ 1,620.00 | |
100 mg | In stock | $ 2,180.00 | |
500 mg | In stock | $ 4,370.00 |
Description | Imitrodast is a small molecule thromboxane A2 synthase (TXA2 synthase) inhibitor for the treatment of immune system disorders, respiratory disorders, and cardiovascular diseases, and can be used in studies of arterial thrombosis, asthma, and coronary vasospasm. |
Molecular Weight | 260.31 |
Formula | C13H12N2O2S |
CAS No. | 114686-12-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Imitrodast 114686-12-3 Proteases/Proteasome Thrombin inhibitor inhibit